Engineers Gate Manager LP Has $6.77 Million Stock Position in West Pharmaceutical Services, Inc. $WST

Engineers Gate Manager LP grew its stake in West Pharmaceutical Services, Inc. (NYSE:WST) by 486.9% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 18,868 shares of the medical instruments supplier’s stock after buying an additional 15,653 shares during the quarter. Engineers Gate Manager LP’s holdings in West Pharmaceutical Services were worth $6,774,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. California State Teachers Retirement System grew its holdings in shares of West Pharmaceutical Services by 36,590.8% during the second quarter. California State Teachers Retirement System now owns 40,592,489 shares of the medical instruments supplier’s stock worth $14,572,704,000 after buying an additional 40,481,855 shares in the last quarter. BlackRock Inc. bought a new stake in West Pharmaceutical Services in the 2nd quarter valued at approximately $2,387,990,000. State Street Corp boosted its position in West Pharmaceutical Services by 2.1% during the 2nd quarter. State Street Corp now owns 3,271,866 shares of the medical instruments supplier’s stock worth $715,884,000 after acquiring an additional 68,330 shares during the last quarter. Artisan Partners Limited Partnership boosted its position in West Pharmaceutical Services by 2.9% during the 4th quarter. Artisan Partners Limited Partnership now owns 2,850,401 shares of the medical instruments supplier’s stock worth $784,259,000 after acquiring an additional 79,481 shares during the last quarter. Finally, Bank of New York Mellon Corp bought a new position in shares of West Pharmaceutical Services during the 2nd quarter worth approximately $733,733,000. 93.90% of the stock is currently owned by institutional investors and hedge funds.

West Pharmaceutical Services Stock Up 0.4%

Shares of WST opened at $345.49 on Friday. West Pharmaceutical Services, Inc. has a one year low of $223.83 and a one year high of $386.00. The company has a market cap of $24.31 billion, a P/E ratio of 44.24, a P/E/G ratio of 2.41 and a beta of 1.14. The company has a debt-to-equity ratio of 0.07, a current ratio of 2.82 and a quick ratio of 2.12. The firm has a 50 day simple moving average of $348.46 and a two-hundred day simple moving average of $310.28.

West Pharmaceutical Services (NYSE:WST) last issued its quarterly earnings results on Thursday, July 23rd. The medical instruments supplier reported $2.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.08 by $0.29. West Pharmaceutical Services had a return on equity of 20.11% and a net margin of 16.98%.The company had revenue of $872.30 million for the quarter, compared to analyst estimates of $839.98 million. During the same quarter last year, the company posted $1.84 EPS. The company’s revenue for the quarter was up 13.8% compared to the same quarter last year. West Pharmaceutical Services has set its Q3 2026 guidance at 2.140-2.240 EPS and its FY 2026 guidance at 8.850-9.050 EPS. Research analysts forecast that West Pharmaceutical Services, Inc. will post 8.93 EPS for the current fiscal year.

West Pharmaceutical Services Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, August 5th. Stockholders of record on Wednesday, July 29th were paid a dividend of $0.22 per share. This represents a $0.88 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date of this dividend was Wednesday, July 29th. West Pharmaceutical Services’s dividend payout ratio (DPR) is presently 11.27%.

Insider Activity at West Pharmaceutical Services

In related news, VP Annette Favorite sold 8,135 shares of the firm’s stock in a transaction that occurred on Tuesday, September 8th. The shares were sold at an average price of $340.81, for a total value of $2,772,489.35. Following the completion of the transaction, the vice president owned 16,845 shares in the company, valued at $5,740,944.45. This trade represents a 32.57% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.60% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on WST shares. Wolfe Research assumed coverage on West Pharmaceutical Services in a report on Monday, June 1st. They issued an “outperform” rating and a $375.00 price objective for the company. Weiss Ratings upgraded West Pharmaceutical Services from a “hold (c)” rating to a “hold (c+)” rating in a report on Friday, August 7th. Citigroup increased their price target on West Pharmaceutical Services from $400.00 to $412.00 and gave the company a “buy” rating in a research report on Monday, August 3rd. Evercore restated an “outperform” rating and issued a $425.00 price target on shares of West Pharmaceutical Services in a research note on Monday, July 27th. Finally, UBS Group upped their price objective on West Pharmaceutical Services from $340.00 to $415.00 and gave the stock a “buy” rating in a research note on Wednesday. One analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $373.85.

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc (NYSE: WST) develops and manufactures components and systems used to package, contain and deliver injectable medicines and other healthcare products. Its customers include pharmaceutical, biotechnology and medical device companies, which use West products in drug administration and medical applications.

The company’s offerings include elastomer components such as stoppers, plungers and seals; syringe and cartridge components; vial and container closure systems; and specialized delivery systems for injectable and other complex medicines.